Koji Mitsuzuka

7PUBLICATIONS
46CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 04, 2023
Improving compliance with guidelines may lead to favorable clinical outcomes for patients with non-muscle-invasive bladder cancer: A retrospective multicenter study.

Takuma Sato, Takeshi Sano, Sadafumi Kawamura

|Jul 05, 2023
Trends in the use of local intervention for metastatic hormone-naïve prostate cancer: A multicenter retrospective study.

Ryuma Tanaka, Shingo Hatakeyama, Shintaro Narita

|Sep 12, 2022
Minimal residual membranous urethral length and membranous urethral length predict poor recovery from incontinence after robot-assisted radical prostatectomy and after open radical prostatectomy.

Eiichiro Ohara, Naoki Kawamorita, Yohei Satake

|Jul 20, 2022
Comparison of the medical costs between active surveillance and other treatments for early prostate cancer in Japan using data from the PRIAS-JAPAN study.

Takuma Kato, Akira Yokomizo, Ryuji Matsumoto

|Jan 26, 2022
Efficacy of combined androgen blockade therapy in patients with metastatic hormone-sensitive prostate cancer stratified by tumor burden.

Yoshiyuki Nagumo, Mizuki Onozawa, Takahiro Kojima

|Jan 18, 2022
Impact of Gleason pattern 5 on prognosis for newly diagnosed metastatic hormone-sensitive prostate cancer with Gleason score ≥8.

Kento Morozumi, Koji Mitsuzuka, Shintaro Narita

Pageof 2

Frequent Collaborators

3 joint publications

Norihiko Tsuchiya

2 joint publications

Shingo Hatakeyama

2 joint publications

Shintaro Narita

2 joint publications

Mikio Sugimoto